Published in Nat Rev Rheumatol on July 20, 2010
Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol (2015) 1.11
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09
Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle (2012) 1.05
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis. Arthritis Rheum (2013) 1.01
Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr (2014) 0.91
Metabolomics--a novel window into inflammatory disease. Swiss Med Wkly (2013) 0.91
LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. J Proteome Res (2014) 0.86
Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis. Clin Rheumatol (2011) 0.86
Subjective and objective levels of physical activity and their association with cardiorespiratory fitness in rheumatoid arthritis patients. Arthritis Res Ther (2015) 0.85
Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther (2012) 0.84
2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation. ACS Med Chem Lett (2014) 0.82
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Perceived Barriers, Facilitators and Benefits for Regular Physical Activity and Exercise in Patients with Rheumatoid Arthritis: A Review of the Literature. Sports Med (2015) 0.82
The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis. J Res Med Sci (2014) 0.82
Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther (2013) 0.81
Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. Croat Med J (2012) 0.80
Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis. PLoS One (2016) 0.80
TNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit Model. Int J Rheumatol (2012) 0.79
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci (2012) 0.78
Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys. BMC Musculoskelet Disord (2013) 0.77
The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord (2016) 0.76
Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis (2016) 0.76
[Treatment of cardiovascular risk factors]. Z Rheumatol (2016) 0.76
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? Arthritis Res Ther (2016) 0.75
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis. Sci Rep (2017) 0.75
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study. Clin Rheumatol (2016) 0.75
[Why rheumatoid arthritis needs cardiologists]. Z Rheumatol (2013) 0.75
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Cachexia: a new definition. Clin Nutr (2008) 5.49
Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation (2003) 4.52
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med (1996) 3.83
Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76
Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr (2006) 2.66
Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) (2003) 2.54
Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum (2003) 2.48
Cachexia. Ann Intern Med (2000) 2.29
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.25
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) (2007) 2.22
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther (2008) 2.15
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum (2005) 2.14
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum (2005) 2.02
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol (2008) 2.02
Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01
TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J (2003) 1.83
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med (2005) 1.77
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis (2004) 1.73
Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum (2004) 1.67
A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis (2007) 1.61
Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years. J Rheumatol (2009) 1.60
Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care (2001) 1.58
Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol (2008) 1.54
Prognostic value of early features in rheumatoid disease. Br Med J (1976) 1.53
Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol (1992) 1.52
Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum (2007) 1.49
Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J (2008) 1.48
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum (2008) 1.45
Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy. Scand J Rheumatol (2007) 1.36
Hypertension in rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.36
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev (2002) 1.29
Weight loss in older persons: new therapeutic approaches. Curr Pharm Des (2007) 1.28
Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) (2007) 1.25
Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) (2007) 1.24
Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol (2003) 1.23
Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) (2008) 1.22
Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum (2001) 1.20
High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol (2008) 1.18
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol (2009) 1.17
Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr (2006) 1.15
Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis (2005) 1.13
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis (1997) 1.13
Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2009) 1.10
Body composition in rheumatoid arthritis. Br J Rheumatol (1997) 1.10
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol (2008) 1.08
Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr (2009) 1.07
Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol (2007) 1.06
Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet (2003) 1.01
Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol (2003) 1.01
No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.97
Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J (2010) 0.94
New resting energy expenditure prediction equations for patients with rheumatoid arthritis. Rheumatology (Oxford) (2008) 0.94
Humoral mediation of changing body composition during aging and chronic inflammation. Nutr Rev (1993) 0.93
Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.93
Body composition in aging: a biological perspective. Curr Opin Clin Nutr Metab Care (2003) 0.91
Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J Rheumatol (2007) 0.90
Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.90
High intensity exercise or conventional exercise for patients with rheumatoid arthritis? Outcome expectations of patients, rheumatologists, and physiotherapists. Ann Rheum Dis (2004) 0.90
The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod Rheumatol (2007) 0.87
Obesity and cardiovascular risk factors in rheumatoid arthritis. Rheumatology (Oxford) (2006) 0.87
Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther (2008) 0.85
Andropause: a quality-of-life issue in older males. Med Clin North Am (2006) 0.83
Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis. Arthritis Care Res (1997) 0.83
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy. J Rheumatol (2005) 0.82
Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol (2004) 0.81
Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol (2007) 0.81
Undernutrition in rheumatoid arthritis patients with disability. Scand J Rheumatol (1996) 0.81
Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol (2010) 0.78
Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des (2011) 4.16
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Biomedical journal editing: elements of success. Croat Med J (2011) 3.06
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol (2005) 2.28
Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am J Respir Crit Care Med (2009) 2.10
Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int (2011) 2.05
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int (2011) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors. Rheumatol Int (2012) 1.52
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Self-correction in biomedical publications and the scientific impact. Croat Med J (2014) 1.44
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J (2013) 1.40
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39
Open access: changing global science publishing. Croat Med J (2013) 1.38
Obesity in rheumatoid arthritis. Rheumatology (Oxford) (2010) 1.32
Upgrading instructions for authors of scholarly journals. Croat Med J (2014) 1.31
Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol (2009) 1.30
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int (2010) 1.28
Promoting transparent and accurate reporting of research studies in rheumatology: endorsement of reporting guidelines in rheumatology journals. Semin Arthritis Rheum (2013) 1.23
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2009) 1.22
The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J (2010) 1.21
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J Health Psychol (2005) 1.20
Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis (2008) 1.19
Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Mol Physiol (2009) 1.18
Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 1.16
Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal (2010) 1.13
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int (2011) 1.12
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2008) 1.11
Multidisciplinary bibliographic databases. J Korean Med Sci (2013) 1.11
Inverted BMI rather than BMI is a better proxy for percentage of body fat. Ann Hum Biol (2011) 1.11
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol (2010) 1.10
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. Br J Health Psychol (2007) 1.05
Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis (2012) 1.01
Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium (2008) 0.99
Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther (2008) 0.99
Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol (2010) 0.99
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.99
The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum (2013) 0.97
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2011) 0.96
An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest (2005) 0.95
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 0.95
Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum (2009) 0.94
Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J (2010) 0.94
Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther (2011) 0.94
Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) (2013) 0.93
Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets (2010) 0.92
Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open (2013) 0.91
Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis (2013) 0.91
Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis (2010) 0.91
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol (2010) 0.89
Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) (2014) 0.89
Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white coat" phenomenon. Arthritis Res Ther (2013) 0.87
Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev (2013) 0.87
Free radicals and redox signalling in T-cells during chronic inflammation and ageing. Biochem Soc Trans (2011) 0.87
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des (2012) 0.87
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade. Clin Rheumatol (2014) 0.86
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. J Rheumatol (2005) 0.86
Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther (2008) 0.85
Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis. Nat Rev Rheumatol (2012) 0.85
Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function. Am J Physiol Endocrinol Metab (2007) 0.85
Suprarenal graft fixation in endovascular abdominal aortic aneurysm repair is associated with a decrease in renal function. J Vasc Surg (2012) 0.85
Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer. Anticancer Res (2014) 0.84
Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther (2012) 0.84
Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol (2011) 0.84
Secondhand smoke exposure induces acutely airway acidification and oxidative stress. Respir Med (2012) 0.84
Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology (2010) 0.84
A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford) (2012) 0.84
Cardiorespiratory and immune response to physical activity following exposure to a typical smoking environment. Heart (2010) 0.83
Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Curr Med Chem (2015) 0.83
Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake. Free Radic Biol Med (2005) 0.83
Fostering autonomous motivation, physical activity and cardiorespiratory fitness in rheumatoid arthritis: protocol and rationale for a randomised control trial. BMC Musculoskelet Disord (2014) 0.83
Abdominal aortic aneurysm: a review of the genetic basis. Angiology (2010) 0.82